Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing methods to measure bone density using CT scans

Official title: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans

Run by Istituto Ortopedico Rizzoli · NCT06454617 · Data updated 2026-11-12

This study tests new ways to measure bone density using CT scans to help people with osteoporosis get better diagnoses and care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Drugs / interventionsradiation
Locations2 sites (Bologna, Bo and 1 other locations)
StatusRecruiting
StartedJune 6, 2024
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedJune 10, 2025
Trial IDNCT06454617 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who require a CT scan of the lumbosacral spine or abdomen for any clinical indication.

Probably not a fit

Patients with severe degenerative conditions of the spine, significant scoliosis, or those with contraindications to CT scans may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates different calibration methods for quantifying bone mineral density (BMD) using CT scans, aiming to improve the diagnosis and management of osteoporosis. It focuses on patients who are undergoing CT scans of the lumbosacral spine or abdomen, assessing the effectiveness of phantomless calibration techniques. By analyzing the data collected from these scans, the study seeks to enhance the detection of fracture risk associated with osteoporosis. The goal is to provide a more accessible and accurate means of diagnosing this prevalent condition.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and management of osteoporosis, potentially reducing the risk of fractures in patients.

How similar studies have gone: While the approach of using CT scans for opportunistic analysis of bone density is gaining interest, this specific calibration method is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both sexes.
* All ethnicities.
* Age equal or above 18 years.
* Any clinical indication (no specific pathology is required) for a CT scan of the lumbosacral spine or abdomen in which the entire lumbar spine (L1 to L5), paravertebral muscles, abdominal aorta, and subcutaneous adipose tissue are visible.
* Ability to give informed consent.

Exclusion Criteria:

* General contraindications to CT examination, including pregnancy or body weight/size exceeding scanner limits.
* Severe degenerative manifestations of the lumbosacral spine.
* Severe scoliosis of the lumbosacral spine.
* Surgical hardware that prevents adequate CT scanning.
* Oncologic pathology in progress or in recent history.
* Any other situation deemed incompatible with the study by the designated physician or investigator.

Where it's running

  • The Rizzoli Orthopaedic Institute
    Bologna, Bo, Italy
    Recruiting
  • Auckland Hospital - Greenlane Clinical Centre - National Women's Hospital
    Auckland, New Zealand
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.